Proteomics of breast cancer - Principles and potential clinical applications

被引:59
作者
Bertucci, Francois
Birnbaum, Daniel
Goncalves, Anthony
机构
[1] Inst J Paoli I Calmettes, Dept Mol Oncol, Ctr Rech Cancerol Marseille, F-13009 Marseille, France
[2] Univ Mediterranee, Fac Med, F-13009 Marseille, France
[3] Univ Mediterranee, Dept Med Oncol, F-13009 Marseille, France
[4] Univ Mediterranee, IPC, Dept Mol Pharmacol, F-13009 Marseille, France
关键词
D O I
10.1074/mcp.R600011-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Progresses in screening, early diagnosis, prediction of aggressiveness and of therapeutic response or toxicity, and identification of new targets for therapeutic will improve survival of breast cancer. These progresses will likely be accelerated by the new proteomic techniques. In this review, we describe the different techniques currently applied to clinical samples of breast cancer and the most important results obtained with the two most popular proteomic approaches in translational research (tissue microarrays and SELDI-TOF).
引用
收藏
页码:1772 / 1786
页数:15
相关论文
共 147 条
  • [41] Laser capture microdissection
    EmmertBuck, MR
    Bonner, RF
    Smith, PD
    Chuaqui, RF
    Zhuang, ZP
    Goldstein, SR
    Weiss, RA
    Liotta, LA
    [J]. SCIENCE, 1996, 274 (5289) : 998 - 1001
  • [42] Data management and analysis for gene expression arrays
    Ermolaeva, O
    Rastogi, M
    Pruitt, KD
    Schuler, GD
    Bittner, ML
    Chen, YD
    Simon, R
    Meltzer, P
    Trent, JM
    Boguski, MS
    [J]. NATURE GENETICS, 1998, 20 (01) : 19 - 23
  • [43] Fine-needle aspiration in. PreservCyt®:: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF
    Fowler, LJ
    Lovell, MO
    Izbicka, E
    [J]. MODERN PATHOLOGY, 2004, 17 (08) : 1012 - 1020
  • [44] Franzen B, 1996, INT J CANCER, V69, P408, DOI 10.1002/(SICI)1097-0215(19961021)69:5<408::AID-IJC10>3.3.CO
  • [45] 2-9
  • [46] Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins
    Franzen, B
    Linder, S
    Alaiya, AA
    Eriksson, E
    Uruy, K
    Hirano, T
    Okuzawa, K
    Auer, G
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1632 - 1638
  • [47] Giltnane JM, 2004, NAT CLIN PRACT ONCOL, V1, P104, DOI 10.1038/ncponc0046
  • [48] Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer
    Ginestier, C
    Bardou, VJ
    Popovici, C
    Charafe-Jauffret, E
    Bertucci, F
    Geneix, J
    Adélaïde, J
    Chaffanet, M
    Hassoun, J
    Viens, P
    Jacquemier, J
    Birnbaum, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) : 854 - 862
  • [49] Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
    Ginestier, C
    Charafe-Jauffret, E
    Bertucci, F
    Eisinger, F
    Geneix, J
    Bechlian, D
    Conte, N
    Adélaïde, J
    Toiron, Y
    Nguyen, C
    Viens, P
    Mozziconacci, MJ
    Houlgatte, R
    Birnbaum, D
    Jacquemier, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) : 1223 - 1233
  • [50] Meeting highlights:: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
    Goldhirsch, A
    Glick, JH
    Gelber, RD
    Coates, AS
    Thürlimann, B
    Senn, H
    Albain, KS
    Bergh, J
    Castiglione-Gertsch, M
    Coates, AS
    Costa, A
    Cuzick, J
    Davidson, N
    Forbes, JF
    Gelber, RD
    Goss, P
    Harris, J
    Glick, JH
    Goldhirsch, A
    Howell, A
    Ingle, JN
    Jakesz, R
    Jassem, J
    Kaufmann, M
    Martin, M
    Mauriac, L
    Morrow, M
    Mouridsen, HT
    Namer, M
    Piccart-Gebhart, MJ
    Possinger, K
    Pritchard, K
    Rutgers, EJT
    Thürlimann, B
    Viale, G
    Wallgren, A
    Wood, WC
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (10) : 1569 - 1583